U.S. Markets open in 16 hrs, 37 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.07 | 23.77 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 5.55 01:27 PM EST | |
|---|---|---|
| Day High | 5.74 03:59 PM EST |
|
| Range | 0.19 |
| Volume | 15,530 | |
|---|---|---|
| 30-Day Avg Vol | 31,000 |
|
| Difference | -49.90% |
| Market Cap | 149.90 M | |
|---|---|---|
| Mkt Cap Chg | 4.97 M |
| Shares Out | 26.16 M | |
|---|---|---|
| % Shrs Traded | 0.06% | |
| 1yr EPS Est | -1.80 |
| 52-Wk Low | 4.77 | |
|---|---|---|
| 52-Wk High | 8.985 |
|
| Range | 4.21 |
| Prev Close | 5.54 11/6/09 | |
|---|---|---|
| Today's Open | 5.57 | |
| Change | 0.54% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 645,701.00 |
| Revenue (LFY) | 83.44 M | |
|---|---|---|
| Earnings (LFY) | 23.65 M | |
| Earnings (MRQ) | -11.32 M | |
| Next Earn Est | -0.437 | |
| Next Earnings | 02/08/2010 |
|
| EPS (TTM) | 1.09 | |
| 1yr EPS Growth | -300.00% |
| P/E Ratio (TTM) | 5.26 | |
|---|---|---|
| P/E Ratio (Fwd) | -3.00 | |
| PEG Ratio | — | |
| Return on Equity | 29.92 | |
| Beta | 0.43 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Infinity Pharmaceuticals acts on the endless possibilities for new cancer treatments. The firm develops small-molecule anti-cancer drugs for applications in many types of cancer therapy. Its most advanced ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.437 12:00 AM EST | — — |
—
—
|
| Last Quarter | -0.495 6/30/09 | -0.43 6/30/09 |
0.065
Beat
|
| 2 Quarters Ago | -0.073 3/31/09 | -0.15 3/31/09 |
-0.077
Missed
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 13.17 M | 83.44 M |
| Gross Profit | 50.16 M | 36.06 M |
| Operating Income | -13.23 M | 19.22 M |
| Net Income | -11.32 M | 23.65 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts